Kimia Biosciences Intrinsic Value
Kimia Biosciences (KIMIABL) median intrinsic value is ₹41.80 from 9 valuation models (range ₹12–₹91), vs current price ₹36.50 — +14.5% upside (Trading Below Median Value), margin of safety 12.7%. Browse KIMIABL balance sheet details for revenue, profit, balance sheet and cash flow data.
KIMIABL Valuation Methods Summary — DCF, Graham Number & P/E
Kimia Biosciences intrinsic value across 9 models vs current price ₹36.50 — upside/downside and value range per method. Also explore KIMIABL share price data to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹41.80 | ₹33.44 - ₹50.16 | +14.5% | EPS: ₹1.90, Sector P/E: 22x |
| Book Value Method | asset | ₹40.00 | ₹36.00 - ₹44.00 | +9.6% | Book Value/Share: ₹20.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹73.00 | ₹65.70 - ₹80.30 | +100.0% | Revenue/Share: ₹254.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹73.00 | ₹65.70 - ₹80.30 | +100.0% | EBITDA: ₹21.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹91.25 | ₹73.00 - ₹109.50 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹12.16 | ₹10.94 - ₹13.38 | -66.7% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹28.53 | ₹25.68 - ₹31.38 | -21.8% | Revenue Growth: 0.2%, Adj P/E: 15.0x |
| ROE Based Valuation | profitability | ₹73.00 | ₹65.70 - ₹80.30 | +100.0% | ROE: 90.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹29.24 | ₹26.32 - ₹32.16 | -19.9% | EPS: ₹1.90, BVPS: ₹20.00 |
KIMIABL Intrinsic Value vs Market Price — All Valuation Models
Kimia Biosciences fair value range ₹12–₹91 vs current market price ₹36.50 across 9 valuation models. For current market price and key ratios, visit KIMIABL screener.
KIMIABL Intrinsic Value Analysis — Undervalued or Overvalued?
Kimia Biosciences median intrinsic value ₹41.80, current price ₹36.50 — Trading Below Median Value by 14.5%, margin of safety 12.7%.
What is the intrinsic value of KIMIABL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Kimia Biosciences (KIMIABL) is ₹41.80 (median value). With the current market price of ₹36.50, this represents a +14.5% variance from our estimated fair value.
The valuation range spans from ₹12.16 to ₹91.25, indicating ₹12.16 - ₹91.25.
Is KIMIABL undervalued or overvalued?
Based on our multi-method analysis, Kimia Biosciences (KIMIABL) appears to be trading below median value by approximately 14.5%.
KIMIABL Financial Health — Key Ratios vs Industry Benchmarks
Kimia Biosciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.95 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 90.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 15.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.14x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
KIMIABL Cash Flow Quality — Operating & Free Cash Flow
Kimia Biosciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹21 Cr | ₹19 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹15 Cr | ₹14 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-7 Cr | ₹-9 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹8 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹6 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |